HER2+ Early-Stage Breast Cancer with Ruth O'Regan, MD Case 1
HER2+ Early-Stage Breast Cancer with Ruth O'Regan, MD
Case Scenario 1:
- This is a post-menopausal 58-year-old female in whom a mass was discovered in her right breast during her annual mammography.
- Her gynecologist referred her to a breast surgeon; results of her biopsy revealed 3 cm ductal carcinoma
- Pathology shows: ER & PR–, HER2 IHC 3+
- Clinical staging; T2aN1M0
- Her surgeon discussed the patient’s case at the Breast Tumor Board and it was suggested that the patient be referred to a medical oncologist for consideration of HER2-targeted neoadjuvant therapy.
- The surgeon shared his opinion with the patient who agreed to go to the medical oncologist to discuss her options.
Related Videos
Related Content
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020Podcast
In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
Experts Warn of Radiation Overtreatment in Older Women With Early-Stage Breast Cancer
March 20th 2024Article
Studies have found that omitting radiation therapy after breast-conserving surgery and/or omitting axillary surgery in women age 70 years or older does not affect their survival when taking endocrine therapy.
Read More
